Genitourinary Radiology: Page 2

What skillset do you need for reporting prostate MRI scans?

By Philip Ward

Radiologists reporting prostate multiparametric MRI exams must be familiar with the latest clinical recommendations and the potential pitfalls mimicking malignant lesions during diagnosis, active surveillance, and recurrence assessment, a leading Spanish research team has asserted.

April 18, 2023

Advantis gets clearance for MRI analysis software

By AuntMinnieEurope.com staff writers

Dutch-based imaging software developer Advantis Medical Imaging has garnered U.S. Food and Drug Administration clearance for its Advantis Platform brain and prostate MRI analysis software.

April 16, 2023

Imaging sheds light on complex cases of penile trauma

By Philip Ward

Multiparametric ultrasound is an ideal diagnostic tool for penile traumatic injuries because it has a high resolution and is portable, safe, and widely available, prize-winning researchers from Madrid and London reported at ECR 2023.

March 29, 2023

Simple x-ray protocol can reduce radiation dose in obese patients

By Will Morton

Having obese patients use handheld cotton bands to move belly fat during pelvic x-ray examinations can reduce their radiation exposure and improve image quality, a Slovenian study has found.

March 27, 2023

Spanish team underlines clinical value of rectal cancer MRI

By Philip Ward

MRI is a valuable tool for assessing critical anatomical landmarks and features that determine the prognosis and management of rectal cancer patients, a leading research group reported at ECR 2023. The modality's also useful for tumor staging and restaging.

March 21, 2023

Swedish group revises iodinated CT contrast guidelines

By AuntMinnieEurope.com staff writers

The Swedish Society of Uroradiology has revised the CT guidelines for iodinated contrast-induced acute kidney injury.

February 13, 2023

MRI-targeted prostate biopsies can drastically cut overdiagnosis

By Kate Madden Yee

A new approach to prostate cancer biopsy based on targeted MRI rather than systemic ultrasound shows promise for reducing overdiagnosis by up to half, Swedish scientists stated on 8 December in the New England Journal of Medicine.

December 11, 2022

Blue Earth moves toward U.K. prostate radiopharmaceutical licensing

By AuntMinnieEurope.com staff writers

Blue Earth Therapeutics has secured an "innovation passport" from the U.K.'s Innovative Licensing and Access Pathway for its investigational therapeutic radiopharmaceutical lutetium-177 rhPSMA-10.1 for treatment of metastatic prostate cancer.

November 8, 2022

Quibim secures CE mark for QP-Prostate

By AuntMinnieEurope.com staff writers

Quibim has secured the CE mark for QP-Prostate as a class IIB device, as well as receiving UKCA certification.

October 27, 2022

MR-guided biopsies and transurethral ablation give hope in prostate care

By Mélisande Rouger

PARIS -- Clinical advances in MRI-guided percutaneous diagnosis and emerging treatment options for prostate tumors were discussed in depth during a special session at the French national radiology congress, JFR 2022.

October 10, 2022

Spotlight falls on cancer detection rates in prostate MRI

By Philip Ward

Dynamic contrast enhancement can help identify clinically significant cancers in prostate multiparametric MRI at 1.5 tesla, but the effect is smaller at 3 tesla and there is a higher risk of overdiagnosis due to detection of additional low-risk cancers, German researchers have reported.

September 14, 2022

Novel ultrasound method can boost prostate cancer risk assessment

By Amerigo Allegretto

A nomogram prediction model that uses contrast-enhanced ultrasound can help predict prostate cancer risk, a new study has found. The authors hope the new technique will lead to a meaningful reduction in unnecessary biopsies.

August 4, 2022

Previous Page

Page 2 of 21

Next Page